Foghorn Therapeutics appoints Jeff Sacher as interim CFO effective Dec 3, 2025

Foghorn Therapeutics Inc.

Jeff Sacher appointed as Treasurer and interim CFO, effective immediately; company continues search for permanent CFO.
Sacher is a CFO at Danforth Advisors, which will be paid an hourly rate for interim CFO services plus expenses.
Sacher has 35 years in biotech and investment banking, with an MBA from Kellogg and a BA from Cornell.
No family relationships with any executive officers or directors; no other arrangements for his appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.